Jump to ContentJump to Main Navigation
Race in a Bottle
Users without a subscription are not able to see the full content.

Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age

Jonathan Kahn

Abstract

At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, “I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms, all human beings, regardless of race, are more than 99.9 percent the same.” Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that 0.1 percent of difference, particularly as it relates to race. This trend is exemplified by the drug BiDil. This drug was originally touted as a groundbreaking therapy to treat ... More

Keywords: biomedical research, BiDil, drugs, race, biomedicine, genomics, racism, health disparity, social injustice

Bibliographic Information

Print publication date: 2014 Print ISBN-13: 9780231162999
Published to Columbia Scholarship Online: November 2015 DOI:10.7312/columbia/9780231162999.001.0001

Authors

Affiliations are at time of print publication.

Jonathan Kahn, author
Hamline University School of Law